CSL said it intends to use the US$4 billion in proceeds from the bond offering to partially finance the proposed acquisition and for "general corporate purposes." …
Latest Video
New Stories
-
Immutep’s efti combination meets primary endpoint in Phase 2 soft tissue sarcoma
May 26, 2025 - - Australian Biotech -
Life science leaders on Australia's strengths and the opportunity to do more
May 25, 2025 - - Latest News -
USTR invites stakeholder input on the impact of price suppressing policies
May 25, 2025 - - Latest News -
Health department goes for semantics in updated response to uncertified claims collection
May 25, 2025 - - Latest News -
Merck joins with Omico to improve access to cancer trials in Australia
May 22, 2025 - - Latest News -
New Zealand announces 12-month prescriptions in 2025 Budget
May 22, 2025 - - Latest News -
'I think we have to step up and help him to understand that he's got to deliver on it'
May 22, 2025 - - Latest News